Whether the decrease of Nrf2 and HO-1 expression associated with artemisinin treatment has implications for cellular recovery, detoxification and neurological outcomes in severe and CM in humans remains to be determined but theoretically inhibiting these pathways could have a negative impact on malaria outcomes [38, 49, 51, 70, 71]. Here, HMOX1 is linked to malaria.